As conversations around athletic performance evolve, recovery has become just as important as training. Professional athletes are now placing greater emphasis on quality sleep, stress management, and mental resilience, recognizing that peak performance depends on how effectively the body and mind recover.

Reflecting this growing focus, Pulsetto has unveiled its biggest brand campaign yet, featuring NBA players Jonas Valančiūnas and Matas Buzelis. The campaign introduces the concept of Stress Fitness, highlighting the belief that the nervous system can be strengthened through regular training in much the same way as muscles. Titled "Calm Is a Habit. Train For It.", the initiative launches during the NBA offseason, a period when players prioritize recovery, conditioning, and preparation for the upcoming season.

Shared Challenges Across Different Careers
Pulsetto's relationship with NBA athletes began in 2025 through a partnership with All-Star Domantas Sabonis before expanding to include Valančiūnas and Buzelis. Although the two players are at very different stages of their careers—Valančiūnas as a seasoned veteran and Buzelis as one of the league's emerging talents—they describe experiencing similar challenges related to stress, recovery, sleep, and maintaining mental focus.

Rather than simply promoting the brand, both athletes discuss the recovery habits they rely on to unwind, improve sleep quality, and prepare for the physical and mental demands of professional basketball.

Matas Buzelis explains that pressure is part of competing at the highest level. According to him, post-game adrenaline often makes it difficult to relax, and incorporating Pulsetto into his nighttime routine helps him unwind, fall asleep more easily, and make recovery a daily priority.

Jonas Valančiūnas shares a similar perspective, noting that an active mind filled with thoughts about upcoming games and responsibilities can interfere with rest. He says he uses Pulsetto before bedtime to quiet his thoughts, emphasizing that quality sleep directly influences performance the following day.

Their experiences reinforce Pulsetto's philosophy that recovery is an active process and that resilience can be developed through consistent nervous system training rather than being viewed as an innate ability.

Research Supporting Stress Fitness
Pulsetto's technology uses non-invasive vagus nerve stimulation with the goal of helping users improve resilience over time instead of only addressing stress after it has built up.

According to a peer-reviewed study indexed on PubMed and published in the American Journal of Physiology, participants who used the device for four weeks reported measurable improvements, including a 56% reduction in depressive symptoms, a 45% decrease in anxiety, a 41% improvement in sleep disturbances, and a 36.7% reduction in cortisol levels.

Dr. Jone Pukėnaitė, Medical & Science Lead at Pulsetto, says that while elite athletes have long recognized recovery as a key component of performance, current research suggests the nervous system also becomes more resilient through repeated training. She notes that improvements in stress regulation, recovery, and sleep are skills that can be strengthened over time rather than fixed characteristics.

Recovery Beyond Professional Sports
Although the campaign features NBA players, its core message is intended for a much wider audience. Pulsetto emphasizes that the body's response to pressure is similar whether someone is preparing for a championship game, an important business presentation, a major exam, or simply managing everyday responsibilities. The company believes that consistent nervous system training can help anyone improve their ability to recover from stress.

The "Calm Is a Habit. Train For It." campaign will roll out across multiple platforms with a hero film, athlete interviews, social media videos, and campaign photography, all aimed at introducing the concept of Stress Fitness and encouraging broader conversations about recovery as a skill that can be developed through regular practice.

After years of consumers tracking health metrics without clear guidance on how to use them, NeuroRester Corp. has unveiled its vision for the next generation of wearable wellness technology. The company today announced the launch of Wearable 2.0, anchored by its flagship devices, NeuroRester and CardioGyms. At the center of this ecosystem is the proprietary NAP (Nightly-Active Protocol), a system developed to transform wearable technology from a passive data-collection tool into an active wellness support platform.

The rise of the "Quantified Self" movement introduced consumers to smartwatches, rings, and other devices capable of measuring metrics such as Heart Rate Variability (HRV), sleep quality, and recovery scores. While these devices provide valuable insights, they often leave users wondering how to translate data into meaningful action. Wearable 2.0 seeks to address this challenge by offering personalized guidance based on the information users already collect.

Moving Beyond Observation
According to NeuroRester Corp., traditional wearable technology has largely focused on monitoring and reporting health information without offering direct support for wellness improvement. Wearable 2.0 introduces a different approach by integrating intelligent data processing and personalized recommendations.
 

NAP: Personalized Wellness Support
Serving as the foundation of the ecosystem, NAP (Nightly-Active Protocol) connects existing wearable devices—including Apple Watch, Oura, and WH—with NeuroRester's hardware solutions. Once users define their wellness goals and preferences within the app, the protocol automatically schedules customized wellness sessions designed to encourage consistent relaxation and recovery habits that fit naturally into daily life.

The Device Ecosystem
NeuroRester
A compact earbud-style device that incorporates Bioboosti technology to help users relax and support a greater sense of calm.

CardioGyms
A flexible wearable that can be worn on the wrist, calf, or integrated into specialized socks, offering comfort throughout the day while supporting relaxation-focused wellness routines.
"People are no longer satisfied with simply receiving reports that indicate poor sleep or low recovery," said NeuroRester Corp.'s Founder and CEO. "They want practical ways to improve how they feel. Wearable 2.0 and NAP help convert health data into simple, personalized wellness actions, shifting the conversation from understanding the numbers to taking meaningful steps based on them."

Availability
Early Access enrollment will begin in mid-June and will be limited to the first 1,000 participants, who will receive special introductory pricing. Broader product availability is planned for July 2026 through NeuroRester's official website.

About NeuroRester Corp.
Headquartered in Campbell, California, NeuroRester Corp. is advancing the Wearable 2.0 category through the development of proprietary wellness technologies. Its innovations, including NAP and Bioboosti, are designed to support natural relaxation, recovery, and overall well-being.

Important Information
Statements regarding these products have not been reviewed by the U.S. Food and Drug Administration. NeuroRester and CardioGyms are intended for wellness purposes only and are not designed to diagnose, treat, cure, or prevent any disease or medical condition. Descriptions of expected wellness benefits are based on product design objectives and user experience goals; outcomes have not been clinically validated and may differ among individuals.

To deliver personalized wellness experiences, NeuroRester Corp. utilizes health information collected from compatible wearable devices.